A radiolabeled substance being studied as an imaging agent in breast cancer. F-18 FES binds to estrogen receptors and gives off radiation that can be detected by a PET scan. The PET scan forms an image that shows where cancer cells with estrogen receptors can be found in the body. It is a type of radioimaging agent. Also called F-18 16 alpha-fluoroestradiol.
